Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defects

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Mar;111(3):298-305. doi: 10.1016/j.tripleo.2010.05.011. Epub 2010 Sep 26.

Abstract

Objectives: The aim of this study was to evaluate the osteogenic and space-providing effect of rhBMP-2 produced in an Escherichia coli expression system (ErhBMP-2) with absorbable collagen block (ACB) as the carrier system in the rat calvarial defect model.

Study design: Eight-millimeter diameter calvarial defects were created in 60 male Sprague-Dawley rats. The animals were divided into 6 groups containing 10 animals each that received sham-surgery control (no material applied), ACB control (ACB alone), or ErhBMP-2/ACB (ACB loaded with 0.025 mg/mL ErhBMP-2). Histological and histometric analysis was performed after 2- and 8-week healing intervals.

Results: On histological observation, the level of bone formation in the defects was generally higher at 8 weeks than at 2 weeks. Surgical implantation of ErhBMP-2/ACB resulted in the enhanced bone regeneration compared with controls. Moreover, the collagen remnants of ACB appeared to be completely resorbed in ACB control and ErhBMP-2/ACB group after 8 weeks. Histometic analysis revealed that the ErhBMP-2/ACB group had a significantly greater augmented area, new bone area, and new bone ratio after 2 and 8 weeks than both control groups. However, there was no difference between 2 and 8 weeks in the ErhBMP-2/ACB group in all aspects of the augmented area, new bone area, and new bone ratio (P < .05).

Conclusion: ErhBMP-2 loaded on ACB can induce favorable bone formation in the rat calvarial defect model, but this collagen carrier in block type did not fulfill the space-maintaining expectations for bone formation by ErhBMP-2.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants*
  • Animals
  • Biocompatible Materials / therapeutic use*
  • Bone Marrow / pathology
  • Bone Matrix / pathology
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins / therapeutic use
  • Bone Regeneration / physiology
  • Calcification, Physiologic / physiology
  • Collagen / therapeutic use*
  • Connective Tissue / pathology
  • Disease Models, Animal
  • Drug Carriers
  • Escherichia coli*
  • Image Processing, Computer-Assisted / methods
  • Male
  • Osteoblasts / pathology
  • Osteocytes / pathology
  • Osteogenesis / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / therapeutic use
  • Skull / pathology
  • Skull / surgery*
  • Time Factors
  • Transforming Growth Factor beta / therapeutic use

Substances

  • Biocompatible Materials
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Drug Carriers
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • recombinant human bone morphogenetic protein-2
  • Collagen